Shares of Eris Lifesciences Ltd rose 4% on debut on Thursday after its Rs1741.1 crore initial public offer (IPO) received a subscription of more than three times when it closed earlier this month.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in